The meeting program is currently in development. Session topics are outlined below and details will be added as they become available.
Four general sessions will be available for all attendees.
Past, Present and Future Development in Pharmacogenomics
The Need for Complex Cellular Models
Nanotechnologies Enabling Drug Delivery
Predictive Risk Scores: Patient Empowerment
Attendees can choose from these twelve parallel sessions.
Implementation of Pharmacogenomic Testing
Stem Cell-based in vitro Systems to Assess Drug Safety, Drug Discovery and Development
New Developments in Therapeutic Drug Monitoring (TDM)
The Use of Artificial Intelligence and Machine Learning in Drug Discovery and Development
Pharmacogenomics, Drug Development and Regulatory Aspects
Novel, Human in vitro Models to Study Diseases and Mechanisms
Emerging Topics in the Field of Drug Transporters
Impact of New Drug Delivery Methodologies on ADME and Safety
Transporter-mediated Drug-drug Interactions and Translation from in vitro to Clinics
New Modalities - New Challenges
Drug-drug Interactions from the Model to the Clinic
Challenges in Today's Drug Research and Development - The Regulator's View
Microphysiological Systems: Current Status and Applications
Current Approaches and Limitations in the Assessment of Drug-induced Liver Injury (DILI)
Drivers of Modern Drug Development
Optional Short Courses
Short courses will be held on Sunday, June 7 and may be added to attendee registrations for an additional fee. Course attendees will receive digital access to course materials and lunch will be provided to all course registrants.
-Omics Technologies Basic Aspects and Potential Applications
Educating Tomorrow's Scientists and Clinicians in Pharmacogenomics and Personalized Therapy